Giovanni Battista Migliori Selected Research

Extensively Drug-Resistant Tuberculosis

1/2020	Should we worry about bedaquiline exposure in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis?
6/2019	Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives.
4/2019	Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation.
1/2019	Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.
4/2018	New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.
1/2018	Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management.
10/2017	Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
7/2017	Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.
5/2017	Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.
3/2017	Classifying new anti-tuberculosis drugs: rationale and future perspectives.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Battista Migliori Research Topics

Disease

51	Tuberculosis (Tuberculoses) 03/2022 - 07/2005
42	Extensively Drug-Resistant Tuberculosis 01/2020 - 01/2007
32	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 03/2022 - 03/2008
7	Infections 03/2022 - 04/2016
5	COVID-19 01/2022 - 01/2020
3	Latent Tuberculosis 06/2019 - 01/2018
3	Pulmonary Tuberculosis 01/2019 - 04/2013
3	HIV Infections (HIV Infection) 10/2016 - 01/2015
3	Coinfection 03/2015 - 09/2013
2	Asthma (Bronchial Asthma) 01/2022 - 12/2020
2	Lung Injury 01/2018 - 04/2016
2	Communicable Diseases (Infectious Diseases) 10/2016 - 10/2016
2	Lung Diseases (Lung Disease) 03/2016 - 05/2010
1	Inflammation (Inflammations) 01/2022
1	Malnutrition (Nutritional Deficiencies) 03/2020
1	Bacterial Infections (Bacterial Infection) 04/2019
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 10/2017
1	Hypothyroidism 05/2017
1	Tuberculoma 07/2016
1	Pleural Empyema (Pyothorax) 07/2016
1	Tuberculous Pericarditis 02/2016
1	Meningeal Tuberculosis (Tuberculous Meningitis) 02/2016
1	Avitaminosis (Vitamin Deficiency) 02/2016
1	Silicosis 12/2015
1	Necrosis 12/2015
1	Noncommunicable Diseases 10/2015
1	Alcoholism (Alcohol Abuse) 01/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2012

Drug/Important Bio-Agent (IBA)

51	Pharmaceutical PreparationsIBA 01/2022 - 01/2007
21	bedaquiline (R207910)IBA 01/2022 - 01/2014
20	OPC-67683IBA 03/2022 - 09/2014
9	Rifampin (Rifampicin)FDA LinkGeneric 01/2020 - 09/2010
9	Linezolid (Zyvox)FDA Link 03/2017 - 10/2009
6	Isoniazid (Ftivazide)FDA LinkGeneric 01/2018 - 09/2010
6	Meropenem (Merrem)FDA LinkGeneric 01/2018 - 06/2013
5	Biomarkers (Surrogate Marker)IBA 03/2020 - 04/2016
5	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 05/2016 - 06/2013
3	Tuberculin (PPD)IBA 03/2022 - 01/2008
3	AntigensIBA 01/2022 - 01/2008
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 02/2016
3	Imipenem FDA Link 05/2016 - 01/2016
3	FluoroquinolonesIBA 01/2016 - 10/2012
2	Monoclonal AntibodiesIBA 07/2021 - 01/2020
2	Interferon-gamma (Interferon, gamma)IBA 03/2020 - 06/2019
2	Antitubercular AgentsIBA 04/2018 - 06/2015
2	pretomanidIBA 01/2018 - 05/2015
2	Clofazimine (Lamprene)FDA Link 03/2017 - 11/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2016 - 01/2016
2	Ertapenem (Invanz)FDA Link 03/2016 - 01/2016
2	VaccinesIBA 10/2015 - 03/2015
2	Moxifloxacin (Avelox)FDA Link 03/2015 - 09/2006
1	BCG Vaccine FDA Link 02/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	COVID-19 VaccinesIBA 07/2021
1	Proteins (Proteins, Gene)FDA Link 03/2020
1	Lopinavir FDA Link 01/2020
1	baricitinibIBA 01/2020
1	remdesivirIBA 01/2020
1	molnupiravirIBA 01/2020
1	casirivimab and imdevimab drug combinationIBA 01/2020
1	sotrovimabIBA 01/2020
1	nirmatrelvir and ritonavir drug combinationIBA 01/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Ivermectin (Mectizan)FDA Link 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Ritonavir (Norvir)FDA Link 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	Janus KinasesIBA 01/2020
1	sarilumabIBA 01/2020
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2017
1	Oxygen (Dioxygen)IBA 09/2016
1	GasesIBA 09/2016
1	Carbapenems (Carbapenem Antibiotics)IBA 03/2016
1	Vitamin B 6IBA 02/2016
1	Nucleic AcidsIBA 10/2015
1	Volatile Organic CompoundsIBA 10/2015
1	Gatifloxacin (Zymar)FDA Link 03/2015
1	SolutionsIBA 01/2015
1	Pyrazinamide FDA LinkGeneric 09/2010
1	Ethambutol (Myambutol)FDA LinkGeneric 09/2010
1	GoldIBA 01/2008
1	Peptides (Polypeptides)IBA 01/2008
1	NucleotidesIBA 07/2005
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 07/2005

Therapy/Procedure

16	Therapeutics 03/2022 - 03/2015
6	Duration of Therapy 01/2020 - 03/2015
3	Drug Therapy (Chemotherapy) 03/2022 - 07/2016
2	Critical Care (Surgical Intensive Care) 04/2019 - 01/2019
2	Art Therapy 01/2015 - 01/2012
1	Combined Modality Therapy 12/2020
1	Continuity of Patient Care 11/2020
1	Operative Surgical Procedures 03/2020
1	Nutritional Support (Artificial Feeding) 04/2019
1	Transplantation 12/2015